Health X Platform Ltd · NSE:HEALTHX
Health X Platform — Sastasundar Ventures — Investor Presentation (October 2024)
11 slides from Health X Platform's investor presentation, Oct 30, 2024
Slide 1: Regulation 30 intimation cover letter to BSE and NSE
SASTASUNDAR VENTURES LIMITED Azimganj House, 2nd floor, 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata – 700017, India. Tel: +91 33 2282 9330; Fax: +91 33 2282 9335 Email: info@sastasundar.com; Website: www.sastasundarventures.com CIN: L65993WB1989PLC047002 Date: 30-10-2024 To To Th
Slide 2: Investor's Update October 2024
&3SastaSundar ——— GROUP Ith & happiness Investor’s Update October 2024 SastaSundar operate digital platforms for Pharmacy, Wellness and Diagnostics, providing Accessible, Affordable, Scalable and Sustainable person-centric Health Care solutions.
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sastasundar Ventures Limited (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
Slide 4: Turning problems into opportunities quote
“Turning problems into opportunities is the hallmark of persistence in business. It’s not the challenges that define success, but the resolve to see every obstacle as a chance to innovate and grow.” 3
Slide 5: We are launching our own SastaSundar APP Soon
Sastasundar APP is back with health and happiness We are launching our own SastaSundar APP Soon SastaSundar APP shall be a B2C platform for: Pharmacy Wellness Diagnostic The name ‘SastaSundar’ is derived from a popular Indian phrase in terms of consumer experience of Savings and Quality. 4
Slide 6: Economics of SastaSundar B2C platform
Economics of SastaSundar B2C platform • SastaSundar Healthtech Private Limited owns the Brand SastaSundar, the Domains Sastasundar.com and Sastasundar.in, alongwith the related Intellectual Property Rights, Technology and Infrastructure necessary to operate the Sastasundar Platform. • We estimate po
Slide 7: Outlook of our B2B business platform Retailer Shakti
Outlook of our B2B business platform Retailer Shakti • We have a positive outlook for our B2B business platform with full control of our B2C platform, the operations will have strong leveraging benefits. • We have reported revenue in Q1 FY25 of Rs.187.8 crore in our vertical of other retailers B2B b
Slide 8: Previous Corporate Structure (Only Relevant Entities)
Previous Corporate Structure (Only Relevant Entities) SastaSundar Ventures Ltd. (SVL) Mitsubishi Corporation & Rohto Pharmaceuticals 72% 28% SastaSundar Healthbuddy Limited (SHBL) Wholesale business to support Flipkart Health Pvt. Ltd. Seller Pharmacy Network of Flipkart Health+ 75.1% 100% 100% 24.9
Slide 9: Change in Corporate Structure – New Structure (Only Relevant Entities)
Change in Corporate Structure – New Structure (Only Relevant Entities) The current structure will change as follows by the said transaction and merger of Retailer Shakti SastaSundar Ventures Ltd. (SVL) Mitsubishi Corporation 72% & Rohto Pharmaceuticals 28% SastaSundar Healthbuddy Limited (SHBL) (Mer
Slide 10: 'Being Genuine' is Our Core Value 'Being Child' is Our Culture
‘Being Genuine’ is Our Core Value ‘Being Child’ is Our Culture 9
Slide 11: Thank You
Company: Thank You SastaSundar Ventures Limited CIN: L65993WB1989PLC047002 Mr. Pratap Singh – Company Secretary Email Id : investors@sastasundar.com www.sastasundarventures.com Investor Relations Partner: Orient Capital (a division of Link Group) Ronak Jain Irfan Raeen Ronak.jain@linkintime.co.in Ir
Sastasundar Ventures — Investor Presentation (October 2024) on 6ix